Dogwood Therapeutics, Inc. (DWTX) › Shareholders' EquityDogwood Therapeutics, Inc. (DWTX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: -$5.02M2020: $29.94M2021: $14.50M2022: $7.33M2023: $3.81M2024: -$10.12M2025: $74.90M$74.90M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$74.90M+839.8%2024-$10.12M-365.9%2023$3.81M-48.0%2022$7.33M-49.5%2021$14.50M-51.6%2020$29.94M+696.7%2019-$5.02M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share